Our Programs

Our Programs

PROGRAMS

The inside story of our important lead programs.

FIND OUT MORE    >>

Our Strategy

Our Strategy

STRATEGY

The scientific trail.... and where we go from here.

FIND OUT MORE    >>

Our Highlights

Our Highlights

HIGHLIGHTS

The latest milestones in our exciting journey.

FIND OUT MORE    >>

Our Investors

Our Investors

INVESTORS

Vital information for our investor community.

FIND OUT MORE    >>

IMAGINE...

...A CANCER TREATMENT THAT KILLED THE FULL RANGE OF CANCER CELLS WITHIN A TUMOR.

Not just the regular (somatic) cancer cells that most anti-cancer drugs seek to destroy, but also the cancer stem cells that cause tumors to regrow and which to date have proven impervious to drugs.

Imagine that we had the ability to do more than just prolong life or to delay the inevitable by a matter of months… but could provide a therapy that delivered long-term remission.

Imagine being able to face that therapy without wondering if the benefits were worth the cost of debilitating side-effects.

THIS IS WHAT NOVOGEN IMAGINES. MORE IMPORTANTLY, NOVOGEN BELIEVES THAT IT HAS THE ABILITY TO CONVERT THAT IMAGINATION INTO REALITY.

Novogen has two breakthrough drug technologies designed to deliver a complementary one-two blow against most forms of cancer.

The first technology is anti-tropomyosin drugs designed to deliver highly selective chemical debulking by targeting cancer somatic cells.

The second technology is a family of super-benzopyran drugs designed to destroy cancer stem cells and residual somatic cancer cells.


WE FIRMLY BELIEVE WE ARE ON THE ROAD TO CONQUERING CANCER. PLEASE BOOKMARK THIS PAGE AND FOLLOW OUR JOURNEY. WE’LL KEEP YOU INFORMED.


LATEST NEWS
SHARE PRICES


0320-novogen-SHAREPRICE_LOGO-AW.png

“Novogen uses breakthrough technology to create drugs that kill aberrant stem cells.”